Hanzel, Jurij
Almradi, Ahmed
Istl, Alexandra C.
Yang, Mei Lucy
Fleshner, Katherine A.
Parker, Claire E.
Guizzetti, Leonardo
Ma, Christopher
Singh, Siddharth
Jairath, Vipul http://orcid.org/0000-0001-8603-898X
Article History
Received: 15 December 2020
Accepted: 3 February 2021
First Online: 26 February 2021
Compliance with Ethical Standards
:
: JH has received speaker’s fees from Biogen, Janssen, and Takeda. AA has no conflict of interest. ACI has no conflict of interest. MLY has no conflict of interest. KAF has no conflict of interest. CEP is an employee of Alimentiv Inc. (formerly Robarts Clinical Trials). LG is an employee of Alimentiv Inc. (formerly Robarts Clinical Trials). CM has received consulting fees from AbbVie, AVIR Pharma Inc., Mylan, Janssen, Pfizer, Alimentiv (formerly Robarts Clinical Trials), and Takeda; speaker’s fees from AbbVie, Janssen, Pfizer, and Takeda; and research support from Pfizer. VJ has received consulting fees from AbbVie, Eli Lilly, GlaxoSmithKline, Arena pharmaceuticals, Genentech, Pendopharm, Sandoz, Merck, Takeda, Janssen, Robarts Clinical Trials, Topivert, Celltrion; and speaker’s fees from Takeda, Janssen, Shire, Ferring, AbbVie, and Pfizer.